Unknown

Dataset Information

0

Fc-GDF15 glyco-engineering and receptor binding affinity optimization for body weight regulation.


ABSTRACT: GDF15 is a distant TGF-β family member that induces anorexia and weight loss. Due to its function, GDF15 has attracted attention as a potential therapeutic for the treatment of obesity and its associated metabolic diseases. However, the pharmacokinetic and physicochemical properties of GDF15 present several challenges for its development as a therapeutic, including a short half-life, high aggregation propensity, and protease susceptibility in serum. Here, we report the design, characterization and optimization of GDF15 in an Fc-fusion protein format with improved therapeutic properties. Using a structure-based engineering approach, we combined knob-into-hole Fc technology and N-linked glycosylation site mutagenesis for half-life extension, improved solubility and protease resistance. In addition, we identified a set of mutations at the receptor binding site of GDF15 that show increased GFRAL binding affinity and led to significant half-life extension. We also identified a single point mutation that increases p-ERK signaling activity and results in improved weight loss efficacy in vivo. Taken together, our findings allowed us to develop GDF15 in a new therapeutic format that demonstrates better efficacy and potential for improved manufacturability.

SUBMITTER: Fung E 

PROVIDER: S-EPMC8076310 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC7709100 | biostudies-literature
| S-EPMC10836939 | biostudies-literature
| S-EPMC4948116 | biostudies-literature
| S-EPMC5131652 | biostudies-literature
| S-EPMC5584586 | biostudies-literature
| S-EPMC3984331 | biostudies-literature
| S-EPMC7234839 | biostudies-literature
| S-EPMC5678939 | biostudies-literature
| S-EPMC4432726 | biostudies-literature
| S-EPMC6748615 | biostudies-literature